Åsa Grauman

Åsa Grauman

Åsa Grauman

Postdoc

Åsa Grauman studies cancer patients' (acute myological leukemia) preferences and perspectives on individualized treatment using algorithms. The research is part of the multidisciplinary VR project MEET-AML, whose goal is to be able to tailor treatment for individual patients using an algorithm that identifies vulnerabilities in leukemia cells' metabolism using -omics data. The project also includes developing ways to integrate patients' preferences, what they want and their own balance between risk and benefit, in the individualized treatment. In her research, she uses preference studies where both qualitative and quantitative methods are included, to understand how people balance their interests and values.

Åsa is also involved in the EU project ENLIGHTENME which studies how urban lighting affects the population's health and well-being. Together with colleagues at CRB, Deborah Mascalzoni and Mirko Ancilotti, Åsa will study the ethical aspects of the project.

Åsa has a master's degree in public health science and has a doctorate in medical science from Uppsala University. Her PhD project was about how people perceive their risk of suffering from heart disease, how people are affected by cardiovascular risk information and their preferences of how risk information should be conveyed. 

E-mail: asa.grauman@crb.uu.se
Phone: +46 18 471 62 44

Recent publications

  • Grauman, Åsa; Hansson, Mats G.; James, Stefan; Hauber, Brett et al.

    Communicating Test Results from a General Health Check: Preferences from a Discrete Choice Experiment Survey

    Part of Patient, p. 649-660, 2021.

    Open access
  • Grauman, Åsa

    Policyrekommendationer: Informera om risk för hjärt- och kärlsjukdomar

    2021.

    Open access
  • Grauman, Åsa

    The publics’ perspective on cardiovascular risk information: Implications for practice

    Open access
  • Grauman, Åsa; Hansson, Mats G.; James, Stefan; Hauber, Brett et al.

    Communicating test results from a general health checkup: the public’s preferences from a discrete choice experiment survey

    Part of Patient Related Outcome Measures, 2021.

    Open access
  • Grauman, Åsa; Veldwijk, Jorien; Stefan, James; Hansson, Mats et al.

    Good general health and lack of family history influence the underestimation of cardiovascular risk: A cross sectional study

    Part of European Journal of Cardiovascular Nursing, 2021.

    Open access
  • Grauman, Åsa; Hansson, Mats G.; Puranen, Arvid; James, Stefan et al.

    Short-term mental distress in research participants after receiving cardiovascular risk information

    Part of PLOS ONE, 2019.

    Open access
  • Grauman, Åsa; Hansson, Mats G.; James, Stefan K; Veldwijk, Jorien et al.

    Exploring research participants' perceptions of cardiovascular risk information-Room for improvement and empowerment

    Part of Patient Education and Counseling, p. 1528-1534, 2019.

    Open access

Informing about cardiovascular risk

Any health care interventions should be made after careful consideration of the benefits and risks for the individual. But experts and the general public sometimes have different views on what the benefit actually is. Understanding how the public perceives risk is important for designing the information correctly: to build on the individual's pre-understanding, to bridge knowledge gaps, and to correct inaccuracies. From a societal perspective, it is also important to ensure that health care efforts are equal. By examining which groups benefit from the efforts, they can be directed towards particularly vulnerable groups and individuals.

This policy brief contains Åsa Grauman's recommendations for how best to inform the public about the risk of cardiovascular disease.

Cardiovascular risk (in Swedish)

Last modified: 2021-10-20